SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > UTI Mutual Fund > UTI Pharma & Healthcare Fund (G)

UTI Pharma & Healthcare Fund (G)

96.743 0.18 (0.18%)

NAV as on 03 Aug, 2015

CRISIL MF RANK

Not Ranked

Scheme Risk Grade

  N.A

N.A

FUND FAMILY : UTI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
ranking by CRISIL

Not Ranked

This scheme is not ranked by CRISIL (for quarter ended Mar 2015) since it does not fulfill certain eligibility criteria of CRISIL

View Top ranked funds in other categories

Benchmark Index:
 
View Historic Graph From     To     

Returns (NAV as on 03 Aug, 2015)

Period Returns (%) Rank #
1 mth 0.9 4
3 mth 2.3 6
6 mth 8.8 6
1 year 36.9 6
2 year 37.0 6
3 year 29.9 3
5 year 21.7 3

# Moneycontrol Rank within Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2015 17.8 -7.5 - - -
2014 0.9 12.6 24.0 2.4 -
2013 -4.1 10.0 5.5 8.3 23.0
2012 6.9 2.3 8.0 4.9 25.0
2011 -7.8 6.1 -7.2 -0.7 -10.0
2010 11.8 8.9 1.4 9.9 37.4

View where it stands within its peers

* Returns over 1 year are Annualised

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised
  1 mth (%) 3 mth (%) 6 mth (%) 1 yr (%) 2 yr (%) 3 yr (%) 5yr (%)
Fund Returns 0.9 2.3 8.8 36.9 37.0 29.9 21.7
Category avg 1.2 4.1 10.7 41.4 42.0 33.1 24.0
Difference of Fund returns and Category returns -0.3 -1.8 -1.9 -4.5 -5.0 -3.2 -2.3
Best of category 3.6 5.7 14.3 48.2 48.3 38.1 28.5
Worst of category -0.7 2.3 8.8 36.9 37.0 29.9 21.7
Benchmark returns # 0.9 0.4 7.5 35.1 33.0 31.0 24.3
Difference of Fund returns and Benchmark returns 0.0 1.9 1.3 1.8 4.0 -1.1 -2.6
# Benchmark Index: CNX Pharma

Investment Info

Investment Objective

Investment will be made in stocks of companies engaged in manufacturing of Pharmaceuticals bulk drugs, formulations & OTC drugs, medical equipment and accessories, personal healthcare products and also companies owning/managing hospitals etc.

Scheme details

Fund Type Open-Ended
Investment Plan Growth
Launch date Jun 26, 1999
Benchmark CNX Pharma
Asset Size (Rs cr) 245.21 (Jun-30-2015)
Minimum Investment Rs.5000
Last Dividend N.A. View Dividend History
Bonus N.A.
Fund Manager Lalit Nambiar
View performance of schemes managed by the Fund Manager
Notes N.A

Load Details

Entry Load N.A
Exit Load 1.00%
Load Comments Exit Load 1% if redeemed within 1 Year from the date of allotment.

Contact Details

Regd. Office UTI Tower, Gn Block, Bandra-Kurla Complex, Bandra (E), Mumbai, 400051
Tel. No. 66786666
Fax No. 26524921
Email uti@giasbm01.vsnl.net.in
Website http://www.utimf.com

Peer Comparison

Sector - Pharma & Healthcare Crisil Rank Assets (Rs.cr)
3mth (%) 6mth (%) 1yr (%) 3yr (%) 5yr (%)
Reliance Pharma Fund (G) Not Ranked
1,142.05 5.5 9.7 40.8 31.3 21.9
SBI Pharma Fund (G) Not Ranked
451.25 4.6 13.6 46.4 38.1 28.5
UTI Pharma & Health (G) Not Ranked
245.21 2.3 8.8 36.9 29.9 21.7
Reliance Pharma Fund - Direct (G) Not Ranked
78.49 5.7 10.1 41.8 -- --
SBI Pharma Fund - Direct (G) Not Ranked
73.97 5.0 14.3 48.2 -- --
* Returns over 1 year are Annualised More »

Portfolio

Top Holdings (Jun 30, 15)

Equity Sector Value
(Rs cr)
Asset %
Sun Pharma Pharmaceuticals 47.87 19.52
Lupin Pharmaceuticals 32.05 13.07
Dr Reddys Labs Pharmaceuticals 32.00 13.05
Cipla Pharmaceuticals 22.09 9.01
Divis Labs Pharmaceuticals 14.27 5.82
Aurobindo Pharm Pharmaceuticals 14.27 5.82
Glenmark Pharmaceuticals 10.52 4.29
Cadila Health Pharmaceuticals 7.31 2.98
Sun Pharma Adv Pharmaceuticals 7.01 2.86
Ipca Labs Pharmaceuticals 6.30 2.57

Full Portfolio

Sector Allocation (Jun 30, 15)

Sector %

1-Year

HighLow

Pharmaceuticals 94.06 94.73 90.66

View All Sectors

Asset Allocation (%)(Jun 30, 15)

Equity 94.06
Others 0.00
Debt 0.05
Mutual Funds N.A
Money Market 0.00
Cash / Call 5.86

View All

Concentration

Holdings (%)
Top 5 60.47
Top 10 78.99
Sector (%)
Top 3 94.06

News & Videos

Messages & Community

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.